SIGNIFICANCE OF Treg CELLS FOR ADENOSINE-MEDIATED IMMUNE SUPPRESSION IN COLORECTAL CANCER
https://doi.org/10.15789/1563-0625-2017-1-89-94
Abstract
At the present time, immunosuppressive role of extracellular adenosine in carcinogenesis is actively investigated. Colorectal cancer is one of the most common types of malignant neoplasms in Russia and worldwide, but the role of mediators of adenosine-dependent immunosuppression, such as CD39 (that hydrolyze ATP to adenosine), CD73, A2AR, is not yet clear in patients with colorectal cancer. The levels of specific mRNAs for A2AR, ectonucleotidase CD39, and CD73 genes were assayed in white blood cells of the patients with colorectal cancer. The results have shown that the CD39 mRNA content is increased in the patients with colorectal cancer in the course of the disease progression. Meanwhile, no significant difference for CD73 gene expression was found between the patients and healthy donors. Moreover, an increase in A2AR mRNA expression was noted for the patients with advanced colorectal cancer, thus presuming potential activation of adenosine-A2AR-mediated immunosuppressive mechanism. Furthermore, the CD39 expression on T cells was elevated in parallel to the cancer progression. The most significant changes in CD39 expression were observed for both T helper and Treg cell populations at the late stages of colorectal cancer. Similarly, a direct correlation was revealed between CD39 expression on CD4+CD25+CD127lo/-Treg cells, and changes of A2AR mRNA levels in leukocytes from the cancer patients.
About the Authors
G. A. Zhulai
Institute of Biology of Karelian Research Centre, Russian Academy of Sciences
Russian Federation
Russian Federation
Junior Research Associate, Immunology Group,
185910, Karelia, Petrozavodsk, Pushkinskaya str., 11
E. K. Oleinik
Institute of Biology of Karelian Research Centre, Russian Academy of Sciences
Russian Federation
Russian Federation
PhD, MD (Biology), Chief Research Associate, Head, Immunology Group,
Petrozavodsk
A. V. Churov
Institute of Biology of Karelian Research Centre, Russian Academy of Sciences
Russian Federation
Russian Federation
PhD (Biology), Research Associate, Immunology Group,
Petrozavodsk
A. A. Romanov
Republican Cancer Dispensary
Russian Federation
Russian Federation
Oncology Surgeon,
Petrozavodsk
P. N. Kravchenko (Semakova)
Institute of Biology of Karelian Research Centre, Russian Academy of Sciences
Russian Federation
Russian Federation
Junior Research Associate, Immunology Group,
Petrozavodsk
V. M. Оleinik
Institute of Biology of Karelian Research Centre, Russian Academy of Sciences
Russian Federation
Russian Federation
PhD, MD (Biology), Leading Research Associate, Immunology Group,
Petrozavodsk
References
1. Жулай Г.А., Олейник Е.К., Романов А.А., Олейник В.М., Чуров А.В., Кравченко П.Н. Циркулирующие регуляторные Т-клетки и изменения в субпопуляционном составе лимфоцитов у больных колоректальным раком // Вопросы онкологии, 2016. Т. 62, № 1. С. 96-100. [Zhulai G.A., Oleinik E.K., Romanov A.A., Oleinik V.M., Churov A.V., Kravchenko P.N. Circulating regulatory T-cells and changes in the subpopulation composition of lymphocytes in colorectal cancer patients. Voprosy onkologii = Problems in Oncology, 2016, Vol. 62, no. 1, pp. 96-100. (In Russ.)]
2. Циммерман Я.С. Колоректальный рак: современное состояние проблемы // Российский журнал гастроэнтерологии, гепатологии, колопрактологии, 2012. Т. 22, № 4. С. 5-17. [Tsimmerman Ya.S. Colorectal cancer: state-of-the-art. Rossiyskiy zhurnal gastroenterologii, gepatologii, kolopraktologii = Russian Journal of Gastroenterology, Hepatology, Coloproctology, 2012, Vol. 22, no. 4, pp. 5-17. (In Russ.)]
3. Antonioli L., Pacher P., Vizi S.E., Haskó G. CD39 and CD73 in immunity and inflammation. Trends Mol. Med., 2013, Vol. 19, pp. 355-367.
4. Hasko G., Linden J., Cronstein B., Pacher P. Adenosine receptors: therapeutic aspects for inflammatory and immune diseases. Nat. Rev. Drug Discov., 2008, Vol. 7, no. 9, pp. 759-770.
5. Longhi M.S., Robson S.C., Bernstein S.H., Serra S., Deaglio S. Biological functions of ecto-enzymes in regulating extracellular adenosine levels in neoplastic and inflammatory disease states. J. Mol. Med. (Berl), 2013, Vol. 91, pp. 165-172.
6. Mandapathil M., Hilldorfer B., Szczepanski M.J., Czystowska M., Szajnik M., Ren J., Lang S., Jackson E.K., Gorelik E., Whiteside T.L. Generation and accumulation of immunosuppressive adenosine by human CD4+CD25highFOXP3+ regulatory T cells. Journal of Biological Chemistry, 2010, Vol. 285, pp. 7176-7186.
7. Mandapathil M., Szczepanski M.J., Szajnik M., Ren J., Lenzner D.E., Jackson E.K., Gorelik E., Lang S., Johnson J.T., Whiteside T.L. Increased ectonucleotidase expression and activity in regulatory T cells of patients with head and neck cancer. Clin. Cancer Res., 2009, Vol. 15, pp. 6348-6357.
8. Nosho K., Baba Y., Tanaka N., Shima K., Hayashi M., Meyerhardt J.A., Giovannucci E., Dranoff G., Fuchs C.S., Ogino S. Tumour-infiltrating T-cell subsets, molecular changes in colorectal cancer, and prognosis: cohort study and literature review. J. Pathol., 2010, Vol. 222, pp. 4350-4366.
9. Ohta A., Gorelik E., Prasad S.J., Ronchese F., Lukashev D., Wong M.K., Huang X., Caldwell S., Liu K., Smith P., Chen J.F., Jackson E.K., Apasov S., Abrams S., Sitkovsky M. A2A adenosine receptor protects tumors from antitumor T cells. Proc. Natl. Acad. Sci. USA, 2006, Vol. 103, pp. 13132-13137.
10. Zhou Q., Yan J., Putheti P., Wu Y., Sun X., Toxavidis V., Tigges J., Kassam N., Enjyoji K., Robson S.C., Strom T.B., Gao W. Isolated CD39 expression on CD4+ T cells denotes both regulatory and memory populations. Am. J. Transplant., 2009, Vol. 9, pp. 2303-2311.
Review
For citations:
Zhulai G.A., Oleinik E.K., Churov A.V., Romanov A.A., Kravchenko (Semakova) P.N., Оleinik V.M. SIGNIFICANCE OF Treg CELLS FOR ADENOSINE-MEDIATED IMMUNE SUPPRESSION IN COLORECTAL CANCER. Medical Immunology (Russia). 2017;19(1):89-94. (In Russ.) https://doi.org/10.15789/1563-0625-2017-1-89-94
Views:
1147
Email this article 